[1]
|
Tan WJ, Zhao X, Ma XJ, Wang WL, Niu PH, Xu WB, et al. A novel coronavirus genome identified in a cluster of pneumonia cases — Wuhan, China 2019−2020. China CDC Wkly 2020;2(4):61 − 2. http://dx.doi.org/10.46234/ccdcw2020.017CrossRef
|
[2]
|
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382(8):727 − 33. http://dx.doi.org/10.1056/NEJMoa2001017CrossRef
|
[3]
|
Rambaut A, Holmes EC, O’Toole Á, Hill V, McCrone JT, Ruis C, et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assistgenomic epidemiology. Nat Microbiol 2020;5(11):1403 − 7. http://dx.doi.org/10.1038/s41564-020-0770-5CrossRef
|
[4]
|
GISIAD in the News. Novel variant 501Y.V2 with triple spike receptor binding site substitutions. https://www.gisaid.org/references/gisaid-in-the-news/novel-variant-combination-in-spike-receptor-binding-site/. [2021-01-07].https://www.gisaid.org/references/gisaid-in-the-news/novel-variant-combination-in-spike-receptor-binding-site/ |
[5]
|
Chen HY, Huang XY, Zhao X, Song Y, Hao P, Jiang H, et al. The first case of new variant COVID-19 originating in the United Kingdom detected in a returning student — Shanghai Municipality, China, December 14, 2020. China CDC Wkly 2021;3(1):1 − 3. http://dx.doi.org/10.46234/ccdcw2020.270CrossRef
|